SIRT2-IN-20

SIRT2-IN-20 is a SIRT2 inhibitor (human SIRT2 IC50 = 0.5 nM). SIRT2-IN-20 attenuates catalytic turnover by binding to NAD+ (HY-B0445) without forming a covalent adduct. SIRT2-IN-20 inhibits the deacetylation activity of SIRT2 and SIRT1. SIRT2-IN-20 shows cellular target engagement in live cells and induces α-tubulin hyperacetylation in cancer cells, and can be used for research on prostate cancer.

For research use only. We do not sell to patients.

  • Formula: C30H57N5O4S
  • Molecular Weight:583.87
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00